Novo Nordisks

16 May

Novo Nordisk CEO Lars Fruergaard Jørgensen Steps Down Amid Stock Drop

The Danish pharmaceutical giant Novo Nordisk's CEO Lars Fruergaard Jørgensen is leaving his post, according to a press release from the company. A certain connection to the share price drop is hinted at by the board as the reason.

Business

7 May

Novo Nordisk Shares Climb 4 Percent Despite Lowered 2025 Forecast

The Danish Novo Nordisk reports an unexpectedly strong result for the first quarter of the year. But the forecast for the full year 2025 is lowered. Overall, the interim report from one of the world's largest manufacturers of weight loss preparations is interpreted positively.

Business

4 Dec

Eli Lilly: Our weight loss drug beats the Danes

The American pharmaceutical company Eli Lilly claims that its weight loss preparation Zepbound has surpassed its arch-rival Novo Nordisk's Wegovy in a first test, where the two best-sellers were pitted against each other.

Business

You're up to date in Novo Nordisks

That's every story in Novo Nordisks for now.